Procter & Gamble Health Announces First Quarter Results

Procter & Gamble Health Limited today announced its financial results for the quarter ended September 30, 2024. The company reported sales of Rs. 310 crores, up 3% vs. year ago. The company reported Profit After Tax (PAT) of Rs.82 crores, up 26% vs. year ago. Operational PAT is up 8% vs. year ago, excluding one-time impact in the base period.

Commenting on the results, Mr. Milind Thatte, Managing Director, P&G Health India, said, "Our firstquarter results represent a sequential improvement. Our strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution, and value), constructive disruption and an agile accountable organization".

He further added, "We are dedicated to enhancing consumer awareness programs and strengthening our relationships with our customers and stakeholders. We continue to invest in initiatives that address the evolving needs of both consumers and healthcare professionals, along with strengthening our go-to-market model. We have also strengthened our reach, distribution, and retail execution, positioning us for long-term competitiveness".

Shares of Procter & Gamble Health Limited was last trading in BSE at Rs. 5279.05 as compared to the previous close of Rs. 5196.40. The total number of shares traded during the day was 1330 in over 452 trades.

The stock hit an intraday high of Rs. 5370.00 and intraday low of 5252.60. The net turnover during the day was Rs. 7055824.00.

Source : Equity Bulls

Keywords

ProcterandGambleHealth INE199A01012 PGHL Pharmaceuticals Q1FY25 ResultUpdate